British Company Medi-Immune Named in Business Worldwide Magazine's Top 20 to Watch 2019

Medi-Immune's primary focus is to provide immediate protection against all airborne pathogens whilst providing first class respiratory protection, saving money and lives. Having invented, developed and then tested its new technology at PHE Porton Down, the firm has unveiled its new lifesaving device, ProtectivAir®. This lightweight, wearable technology enables unrestricted everyday activities and uses ultraviolet radiation to sterilise airborne pathogens and disable their ability to reproduce. It has already been proven in in vivo trials to produce a ten billion times reduction in influenza particles.

Medi-Immune's primary focus is to provide immediate protection against all airborne pathogens whilst providing first class respiratory protection, saving money and lives. Having invented, developed and then tested its new technology at PHE Porton Down, the firm has unveiled its new lifesaving device, ProtectivAir®. This lightweight, wearable technology enables unrestricted everyday activities and uses ultraviolet radiation to sterilise airborne pathogens and disable their ability to reproduce. It has already been proven in in vivo trials to produce a ten billion times reduction in influenza particles.

Another exciting development has seen ProtectivAir® being remodelled and tested within a cabin environment to help prevent transmission of airborne infections by travellers. Initially piloted in automobiles, Medi-Immune plans to adapt the technology to help protect against diseases that travel internationally on aircraft.

John Willcocks, Business Development Consultant, Medi-immune explained: "Essentially, we have created innovative technology that can protect everyone from known and unseen emerging threats. By offering both immediate and long-term protection against new and existing airborne pathogens, we are changing the way science looks at immunisation and airborne viral protection."

With governments around the world under pressure to tackle the imminent threat of pandemics, Medi-Immune will be in the vanguard, providing the solution.

To find out more about the company, visit https://medi-immune.com/ or contact John Willcocks at [email protected].

An article on the company can be found on the Business Worldwide website

https://www.bwmonline.com/2019/11/09/medi-immune-the-british-company-tackling-global-pandemics-with-technology/

About Business Worldwide Magazine

Business Worldwide Magazine is the leading source of business and dealmaker intelligence throughout the world. Our quarterly magazine and online news portal enables an established audience of corporate dealmakers to track the latest news, stories and developments affecting the international markets, corporate finance, business strategy and changes in legislation. This readership includes of CEO/CFO - Banks, Corporate Lawyers and Venture Capital/Private Equity Companies to name a few.

Contact

David Jones
Awards Department
E: [email protected]

W: http://www.bwmonline.com